Findings from a Mass General Brigham-led study that has followed participants since before birth may offer clues about the origins of Alzheimer’s disease.
Heidelberg Pharma Secures Patent for the Use of its ADC Technology Platform – Biotech Investments
EQS-News: Heidelberg Pharma AG / Key word(s): Patent Heidelberg Pharma Secures Patent for the Use of its ADC Technology Platform 15.11.2023 / 09:24 CET/CEST The